Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, Abubakar M, Andrulis IL, Anton-Culver H, Beckmann M, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, Briceno I, Burwinkel B, Camp NJ, Castelao JE, Choi JY, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Devilee P, Dork T, Dunning AM, Dwek M, Easton DF, Eccles DM, Eriksson M, Ernst K, Evans DG, Figueroa JD, Fink V, Floris G, Fox S, Gabrielson M, Gago-Dominguez M, Garcia-Saenz JA, Gonzalez-Neira A, Häberle L, Haiman CA, Hall P, Hamann U, Harkness EF, Hartman M, Hein A, Hooning MJ, Hou MF, Howell SJ, Ito H, Jakubowska A, Janni W, John EM, Jung A, Kang D, Kristensen VN, Kwong A, Lambrechts D, Li J, Manoochehri M, Margolin S, Matsuo K, Taib NAM, Mulligan AM, Nevanlinna H, Newman WG, Offit K, Osorio A, Park SK, Park-Simon TW, Patel A, Presneau N, Pylkas K, Rack B, Radice P, Rennert G, Romero A, Saloustros E, Sawyer EJ, Schneeweiss A, Schochter F, Schoemaker MJ, Shen CY, Shibli R, Sinn P, Tapper WJ, Tawfiq E, Teo SH, Teras LR, Torres D, Vachon CM, Van Deurzen CHM, Wendt C, Williams JA, Winqvist R, Elwood M, Schmidt MK, Pharoah PDP (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 173
Pages Range: 178-193
DOI: 10.1016/j.ejca.2022.06.011
Background: Predict Breast (www.predict.nhs.uk) is an online prognostication and treatment benefit tool for early invasive breast cancer. The aim of this study was to incorporate the prognostic effect of progesterone receptor (PR) status into a new version of PREDICT and to compare its performance to the current version (2.2).
APA:
Grootes, I., Keeman, R., Blows, F.M., Milne, R.L., Giles, G.G., Swerdlow, A.J.,... Pharoah, P.D.P. (2022). Incorporating progesterone receptor expression into the PREDICT breast prognostic model. European Journal of Cancer, 173, 178-193. https://doi.org/10.1016/j.ejca.2022.06.011
MLA:
Grootes, Isabelle, et al. "Incorporating progesterone receptor expression into the PREDICT breast prognostic model." European Journal of Cancer 173 (2022): 178-193.
BibTeX: Download